We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
FDA Approves New Treatment for Moderate-to-Severe Plaque Psoriasis
Biosimilars for the Treatment of Psoriasis
Biosimilars in Psoriasis: The Future of Treatment
Raj Chovatiya, MD, PhD
Steven R. Feldman, MD, PhD
Treating Atopic Dermatitis: A Look at the Current & Future Landscape
Jennifer Soung, MD
Einjuan James Song, MD, FAAD
Applying Shared Decision-Making to Atopic Dermatitis Care
Matthew Zirwas, MD
Douglas DiRuggiero, DMSc, PA-C
Psoriasis Treatment Redefined: Exploring the Impact of IL-23 Inhibitors
George Han, MD, PhD
From Pathophysiology to Therapeutic Progress: TYK2's Significance in Plaque Psoriasis
Breakthroughs in Generalized Pustular Psoriasis Treatment: Exploring Current & Emerging Approaches
Jason E. Hawkes, MD, MS, FAAD
A New Era in Plaque Psoriasis Care: Examining Topical Nonsteroidal Therapies
Reviewing the Role of B Cells in Melanoma
Reviewing New Therapies for Hidradenitis Suppurative
Martina J. Porter, MD
Investigating Hidradenitis Suppurativa: A Multifactorial Disease
Exploring Emerging Therapies for Alopecia Areata
Britt Craiglow, MD
Alopecia Areata: Exploring New Data
Curious Cases in Care: Can You Guess the Diagnosis?
Marshall Miller
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education